| scholarly article | Q13442814 |
| P2093 | author name string | Donghee Kim | |
| Richard L Ehman | |||
| Jayant A Talwalkar | |||
| W Ray Kim | |||
| Hwa Jung Kim | |||
| P2860 | cites work | Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers | Q28258678 |
| Magnetic resonance elastography by direct visualization of propagating acoustic strain waves | Q28290066 | ||
| Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity | Q29614932 | ||
| The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 | ||
| Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C | Q30463023 | ||
| Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography | Q30467234 | ||
| Repeatability of magnetic resonance elastography for quantification of hepatic stiffness | Q30476723 | ||
| Cross-validation of magnetic resonance elastography and ultrasound-based transient elastography: a preliminary phantom study | Q30478930 | ||
| Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension | Q30481806 | ||
| Assessment of hepatic fibrosis with magnetic resonance elastography | Q30493170 | ||
| Liver biopsy | Q33932981 | ||
| Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection | Q34154927 | ||
| Nonalcoholic fatty liver disease: a review of current understanding and future impact | Q35996525 | ||
| Noninvasive measures of liver fibrosis | Q36382285 | ||
| Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive | Q37310296 | ||
| MR imaging of liver fibrosis: current state of the art. | Q37644144 | ||
| Internal and external validation of predictive models: a simulation study of bias and precision in small samples | Q40556623 | ||
| A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. | Q44527614 | ||
| Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection | Q44920531 | ||
| How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited | Q45037291 | ||
| Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations | Q46078112 | ||
| Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease | Q46179069 | ||
| Magnetic resonance elastography for the noninvasive staging of liver fibrosis. | Q46601756 | ||
| Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. | Q51707737 | ||
| Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. | Q52933297 | ||
| Estimating and comparing diagnostic tests' accuracy when the gold standard is not binary. | Q53573938 | ||
| Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis | Q54513263 | ||
| Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients | Q57735452 | ||
| Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard | Q58622618 | ||
| Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages | Q58622710 | ||
| Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease | Q58622754 | ||
| Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C | Q61764154 | ||
| The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD | Q61989968 | ||
| Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies | Q70032258 | ||
| Cross-validation of MR elastography and ultrasound transient elastography in liver stiffness measurement: discrepancy in the results of cirrhotic liver | Q82046940 | ||
| Noninvasive assessment of liver fibrosis | Q83258968 | ||
| Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity | Q83885182 | ||
| Noninvasive assessment of liver fibrosis | Q84051868 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver disease | Q929737 |
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 411-419 | |
| P577 | publication date | 2013-04-05 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography | |
| P478 | volume | 268 |
| Q64104335 | A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease |
| Q47139016 | A prediction model for the grade of liver fibrosis using magnetic resonance elastography |
| Q59330232 | Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis |
| Q36156172 | Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update |
| Q48249679 | Assessment of advanced hepatic MR elastography methods for susceptibility artifact suppression in clinical patients. |
| Q62626273 | Biomarkers of liver fibrosis |
| Q48234623 | Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods. |
| Q30382172 | Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study. |
| Q48337670 | Comparison of diagnostic accuracies of two- and three-dimensional MR elastography of the liver. |
| Q48257652 | Comparison of gradient-recalled echo and spin-echo echo-planar imaging MR elastography in staging liver fibrosis: a meta-analysis |
| Q42247397 | Comparison of interobserver agreement of magnetic resonance elastography with histopathological staging of liver fibrosis |
| Q41706840 | Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease |
| Q38607766 | Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis |
| Q47386319 | Detection of liver fibrosis using qualitative and quantitative MR elastography compared to liver surface nodularity measurement, gadoxetic acid uptake, and serum markers. |
| Q30389544 | Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. |
| Q88794981 | Diagnostic performance of magnetic resonance technology in detecting steatosis or fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis |
| Q35664034 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats |
| Q91783880 | Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese |
| Q39380465 | Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. |
| Q30413592 | Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial) |
| Q92441389 | Feasibility of measuring spleen stiffness with MR elastography and splenic volume to predict hepatic fibrosis stage |
| Q38790052 | Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016. |
| Q37373282 | Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry |
| Q89539952 | Functional MRI as a Tool for Evaluating Interstitial Fibrosis and Prognosis in Kidney Disease |
| Q38224490 | Hepatic steatosis and steatohepatitis: Are they really two distinct entities? |
| Q30368624 | Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study |
| Q31134971 | Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood |
| Q30376231 | Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease |
| Q37488800 | KASL clinical practice guidelines: management of nonalcoholic fatty liver disease |
| Q38600259 | Liver Fibrosis Quantification by Magnetic Resonance Imaging |
| Q42145719 | Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States. |
| Q38867829 | MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice |
| Q38792324 | Magnetic Resonance Elastography Measured Shear Stiffness as a Biomarker of Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. |
| Q26738871 | Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions |
| Q57062900 | Magnetic Resonance Elastography of Liver: Current Update |
| Q38635428 | Magnetic Resonance Elastography to Assess Fibrosis in Kidney Allografts |
| Q30372813 | Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis |
| Q45128165 | Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. |
| Q39697982 | Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study |
| Q91605715 | Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy |
| Q30362976 | Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis |
| Q30364476 | Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study. |
| Q26852613 | Magnetic resonance elastography of abdomen |
| Q30435917 | Magnetic resonance elastography of liver: clinical applications |
| Q53044472 | Magnetic resonance elastography of liver: influence of intravenous gadolinium administration on measured liver stiffness. |
| Q30418856 | Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study |
| Q41288644 | Magnetic resonance elastography: evaluation of new inversion algorithm and quantitative analysis method |
| Q39170830 | Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD). |
| Q53095230 | Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese. |
| Q39034532 | Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era. |
| Q30430958 | NIH workshop on clinical translation of molecular imaging probes and technology--meeting report. |
| Q30400175 | Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C |
| Q47372898 | Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity |
| Q38397177 | Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies |
| Q38494198 | Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives |
| Q30414504 | Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease |
| Q30366569 | Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. |
| Q89216668 | Nonalcoholic fatty liver disease |
| Q40154653 | Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis |
| Q55361713 | Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease. |
| Q38708566 | Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease |
| Q28082686 | Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease |
| Q30355082 | Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease. |
| Q30441644 | Noninvasive assessment of hepatic fibrosis in patients with chronic hepatitis B viral infection using magnetic resonance elastography |
| Q91974913 | Noninvasive assessment of renal fibrosis by magnetic resonance imaging and ultrasound techniques |
| Q30432576 | Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future |
| Q30436164 | Noninvasive diagnosis of cirrhosis: a review of different imaging modalities |
| Q38772737 | Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet? |
| Q38141711 | Noninvasive evaluation of NAFLD. |
| Q42613401 | Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy. |
| Q30366572 | Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study. |
| Q41633785 | Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease |
| Q38229961 | Obesity and the liver: nonalcoholic fatty liver disease |
| Q38504279 | Pattern and profile of chronic liver disease in acute on chronic liver failure |
| Q26795413 | Prediction of liver cirrhosis, using diagnostic imaging tools |
| Q92147100 | Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease |
| Q52692830 | Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. |
| Q57494353 | Recommendations for the management of non-alcoholic fatty liver disease (NAFLD) |
| Q94475611 | Road to identifying endpoint biomarkers in the treatment of nonalcoholic steatohepatitis: are we there yet? |
| Q92604714 | Role and effective therapeutic target of gut microbiota in NAFLD/NASH |
| Q40766803 | Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial |
| Q38923545 | State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization |
| Q48336003 | Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese. |
| Q38676257 | The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases. |
| Q90736920 | The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery |
| Q30422941 | Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging |
| Q28081275 | Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 1, Principles and Techniques |
| Q36359100 | Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease |
| Q40551462 | Weight Loss Decreases Magnetic Resonance Elastography Estimated Liver Stiffness in Nonalcoholic Fatty Liver Disease |
| Q52987727 | [Functional MR imaging of the liver]. |
Search more.